Related Experiment Video
Updated: May 3, 2026

06:27
Transcutaneous Microcirculatory Imaging in Preterm Neonates
Published on: December 31, 2015
7.8K
The coagulation profile of preterm delivery
Anat Keren-Politansky1, Tatiana Breizman2, Benjamin Brenner1
1Hematology Laboratory, Thrombosis and Hemostasis Unit, Haifa, Israel.
Thrombosis Research
|February 11, 2014
Summary
Shortened prothrombin time (PT) and activated partial thromboplastin time (aPTT) indicate increased thrombotic activity. These coagulation markers may help identify true preterm labor in women experiencing premature uterine contractions.
Area of Science:
- Obstetrics and Gynecology
- Hematology
- Reproductive Medicine
Background:
- Preterm birth etiology is often linked to hypercoagulation, but the coagulation status of preterm laboring patients is not fully understood.
- This study aimed to investigate the hemostatic system in pregnant women experiencing premature uterine contractions (PUC).
Purpose of the Study:
- To evaluate the hemostatic system and coagulation activation markers in pregnant women with PUC.
- To determine if coagulation parameters can differentiate between true preterm labor and other causes of PUC.
Main Methods:
- A cohort study involving 76 healthy pregnant women with regular PUC.
- The study included 38 women who delivered preterm (14 with PPROM) and 38 controls who delivered at term.
- Blood samples were analyzed for various hemostatic parameters and coagulation activation markers.
Main Results:
- Significantly shorter prothrombin time (PT) and activated partial thromboplastin time (aPTT) were observed in women with preterm labor compared to controls.
- No significant differences were found in fibrinogen, D-dimer, protein C, protein S, factor VIII, Von Willebrand factor, PAI-1, PT F1+2, tissue factor, or TFPI.
- Women with preterm premature rupture of membranes (PPROM) exhibited lower PT F1+2 levels than those with preterm birth and intact membranes.
Conclusions:
- Shortened PT and aPTT suggest increased thrombotic activity and may serve as a marker for true preterm labor in women with PUC.
- Further large-scale prospective studies are needed to confirm these findings and their clinical utility.
Keywords:
Activated partial thromboplastin timePregnancyPreterm laborProthrombin fragment 1+2Prothrombin timecoagulation activationMore Related Videos
Related Concept Videos
Coagulation
1.5K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.5K
Coagulation
8.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.4K
Fetal Circulation
5.0K
Fetal circulation is a unique system that facilitates the exchange of gases, nutrients, and waste products between the developing fetus and the mother. This intricate process takes place through a special organ called the placenta.
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
Two umbilical arteries transport blood from the fetus to the placenta. At the placenta, the blood absorbs oxygen and nutrients while simultaneously eliminating waste products. This oxygen-enriched and nutrient-rich blood then returns to the fetus through one...
5.0K
Disorders of Hemostasis
2.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
Introduction to Hemostasis
14.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
14.2K
Blood Transfusion and Agglutination
13.0K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
13.0K

